Enhancement of CD38 antibody-mediated phagocytosis of TALL cells by Fc engineering and CD47 blockade

Hilger P, Zeller T, Vogiatzi F, Mueller K, Muennich IA, Windisch R, Wichmann C, Nimmerjahn F, Valerius T, Peipp M, Humpe A, Schewe DM, Kellner C (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 92-92

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Falk Nimmerjahn Lehrstuhl für Genetik

Involved external institutions

Ludwig-Maximilians-Universität (LMU) DE Germany (DE) Christian-Albrechts-Universität zu Kiel DE Germany (DE) Otto-von-Guericke-Universität Magdeburg DE Germany (DE)

How to cite

APA:

Hilger, P., Zeller, T., Vogiatzi, F., Mueller, K., Muennich, I.A., Windisch, R.,... Kellner, C. (2022). Enhancement of CD38 antibody-mediated phagocytosis of TALL cells by Fc engineering and CD47 blockade. In ONCOLOGY RESEARCH AND TREATMENT (pp. 92-92). BASEL: KARGER.

MLA:

Hilger, P., et al. "Enhancement of CD38 antibody-mediated phagocytosis of TALL cells by Fc engineering and CD47 blockade." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2022. 92-92.

BibTeX: Download